In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing To Reach $3.70 Billion By 2030

In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Growth & Trends

The global in-vitro toxicology assays market for cannabis and nicotine testing size is anticipated to reach USD 3.70 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 12.5% from 2025 to 2030. Growing adoption of high throughput techniques in cannabis testing, legalization of medical cannabis, and growing awareness regarding the potential hazards of nicotine consumption have majorly driven the market throughout the forecast period.

The legalization of medical cannabis is underway globally, including in countries such as Germany, Australia, and Israel. The market is gaining momentum in the Asia Pacific region, with Thailand having fully legalized medicinal cannabis. Thus, increasing legalization of medical cannabis is expected to drive the market growth to a major extend. In addition, technological advancements in cellular assays have boosted the market growth.

COVID-19 has become a catalyst for changing the traditional use of cannabis. Owing to the pandemic, the leading scientific community and market competitors are now focusing on deciphering the potential of cannabis to prevent SARS-CoV-2 infection. Companies have reported the increase in the sale of cannabis as some states/countries have declared cannabis as an essential medicine during the pandemic.

 Request a free sample copy or view report summary: In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Report

In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Report Highlights

• Nicotine testing accounted for the largest revenue in 2024 and is expected to continue the trend in the forecast period owing to increasing safety concerns associated with nicotine products.

• Cannabis testing is expected to witness gradual growth through 2025-2030 owing to the rising acceptance of cannabis for medical use.

• 3D cell culture technology is expected to grow at substantial CAGR owing to the increasing popularity of drug development and toxicity testing.

• Cytotoxicity testing designing accounted for the highest market revenue in 2024 owing to advancements in different tools for evaluating the cytotoxic effects of nicotine-containing products.

• North America has emerged as the highest revenue-generating region in 2024, owing to the prevalence of cancer, presence of key players, and developed healthcare infrastructure.

• Asia Pacific is anticipated to witness the fastest CAGR throughout the forecast period. It is anticipated that China and India are contributing majorly to the regional market’s growth.

• Key players are undertaking various strategic initiatives such as mergers and acquisitions to maintain their presence in the market.

In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Segmentation

Grand View Research has segmented the global in-vitro toxicology assays market for cannabis and nicotine testing report based on type, technology, application, method, and region:

In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Cannabis Testing

• Nicotine Testing

In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Technology Outlook (Revenue, USD Billion, 2018 - 2030)

• 3D Cell Culture Technology

• Mass Spectrometry

• Flow Cytometry

• Others

In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Application Outlook (Revenue, USD Billion, 2018 - 2030)

• Genetic Toxicity Testing

• Carcinogenicity Testing

• Cytotoxicity Testing

• Mutagenicity Testing

• Others

In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Method Outlook (Revenue, USD Billion, 2018 - 2030)

• Cellular Assay

  • Live Cells

    • High Throughput / High Content Screening

    • Molecular Imaging

    • Others

  • Fixed Cells

• Others

In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

  • U.S.    

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing

• Stemina Biomarker Discovery, Inc.

• Broughton

• Labstat International, Inc.

• LifeNet Health LifeSciences

• TOXIKON

• Integrated Lab Solutions GmbH

• Enthalpy Analytical

• PBR Laboratories, Inc.